Longeveron Inc. Class A Common Stock (LGVN)

About LGVN

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clini…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

38

Website

www.longeveron.com/

Fundamentals

1-day range

$6.55$7.23

Market cap

$23.13M

P/E (trailing)

—

P/E (forward)

-4.39

EPS (trailing)

$-1.17

Dividend yield

—

Beta

-0.29

Avg. volume

40.4K

Forecasts

3 analyst ratings

Longeveron Inc. Class A Common Stock Competitors

Chosen by industry and closest market cap.

• LGVN

  Longeveron Inc. Class A Common Stock

  $6.72

  ▼ 1.47%
  Market cap $23.13MP/E —
  $4.75$12.3
• CALC

  CalciMedica Inc. Common Stock

  $0.4644

  ▼ 1.19%
  Market cap $23.14MP/E —
  $0.4606$7.2
• BRNS

  Barinthus Biotherapeutics plc American Depositary Shares

  $0.7464

  ▲ 2.11%
  Market cap $24.51MP/E —
  $0.512$1.83
• CLRB

  Cellectar Biosciences Inc. Common Stock

  $2.54

  ▲ 0.00%
  Market cap $21.26MP/E —
  $2.2$6.52
• NEUP

  Neuphoria Therapeutics Inc. Common Stock

  $3.82

  ▲ 1.33%
  Market cap $21.24MP/E —
  $3.19$21.4
• TVRD

  Tvardi Therapeutics Inc. Common Stock

  $1.8

  ▲ 0.00%
  Market cap $25.13MP/E —
  $1.5$43.65
• ACTU

  Actuate Therapeutics Inc. Common stock

  $1.67

  ▼ 1.18%
  Market cap $25.36MP/E —
  $0.9$9.22

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Let's uncover which stocks are experiencing notable gaps during today's session.
  ChartMill · 8/25/2026
• Stay updated with the stocks that are on the move in today's pre-market session.
  ChartMill · 8/25/2026
• Stock Market Today: Dow Jones, S&P 500, Nasdaq 1000 Futures Advance as Scott Bessent Expands Sanctions on Iran—NTS, GRRR, REAX, ZM, LGVN in Focus (UPDATED)
  Benzinga · 8/25/2026
• Dick's Sporting Goods, Intuit And 3 Stocks To Watch Heading Into Tuesday
  benzinga · 8/25/2026
• Dick's Sporting Goods, Intuit And 3 Stocks To Watch Heading Into Tuesday
  Benzinga · 8/25/2026
• Which stocks are moving after the closing bell on Monday?
  ChartMill · 8/24/2026
• 12 Health Care Stocks Moving In Monday's After-Market Session
  Benzinga · 8/24/2026
• Longeveron Announces 1-for-10 Reverse Stock Split, Expected To Become Effective August 26
  Benzinga · 8/24/2026
• Longeveron Appoints Nirav Jhaveri CFO, Succeeding Marie Washburn
  Benzinga · 8/19/2026

• Jhaveri Nirav S. · August 17, 2026 · Grant

  300.0K
• Joshua Hare · July 6, 2026 · Grant

  400.0K
• Joshua Hare · July 6, 2026 · Grant

  600.0K
• Lisa Locklear · July 1, 2026 · Tax Withholding

  22.5K @ $0.7291
• Nataliya Agafonova · July 1, 2026 · Tax Withholding

  22.5K @ $0.7291
• Devin Blass · July 1, 2026 · Tax Withholding

  15.8K @ $0.7291
• Paul T. Lehr · July 1, 2026 · Tax Withholding

  13.1K @ $0.7291
• Stephen H. Willard · July 1, 2026 · Tax Withholding

  18.0K @ $0.7291
• Paul T. Lehr · May 1, 2026 · Grant

  250.0K
• Devin Blass · May 1, 2026 · Grant

  250.0K
• Nataliya Agafonova · May 1, 2026 · Grant

  250.0K
• Lisa Locklear · May 1, 2026 · Grant

  250.0K
• Stephen H. Willard · May 1, 2026 · Grant

  500.0K
• Paul T. Lehr · April 1, 2026 · Tax Withholding

  5.6K @ $1.12
• Nataliya Agafonova · April 1, 2026 · Tax Withholding

  13.1K @ $1.12

Institutional Ownership

March 31, 2026

Total shares held

2.24M

Total value held

$2.21M

Institutional holders

30